Asosiy kontentga oʻtish
Maqola

REVMATOID ARTRIT BILAN KASALLANGAN BEMORLARDA DIPROSPAN-ELEKTROFOREZ QO'LLASH TAJRIBASI

Xamidova Sitora Alisher qiziVitalii B. KaliberdenkoFGAOU VO «V.I. Vernadskiy nomidagi Qrim federal universiteti», S.I. Georgievskiy nomidagi Tibbiyot instituti, Simferopol shahri,Askaraliyeva Shaxruza IskandarovnaNizomiy nomidagi O’zbekiston Milliy Pedagogika Universiteti, Toshkent shahri
2025en
ABI

Annotatsiya

This article presents the experience of using electrophoresis with Diprospan in the treatment of patients with rheumatoid arthritis (RA). The authors emphasize the necessity of finding additional therapeutic methods that provide effective anti-inflammatory action while minimizing systemic side effects. Diprospan is a modern glucocorticoid medication containing two forms of betamethasone (a fast-acting and a long-acting component), which ensures a prolonged anti-inflammatory effect when administered via electrophoresis. The electrophoretic method allows the drug to be delivered directly to the affected area, thereby reducing the risk of systemic adverse effects. The article discusses the clinical effectiveness and advantages of this approach in the management of RA.

Hali tarjima qilinmagan

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba